Timo D. Müller

18.3k total citations · 5 hit papers
144 papers, 6.8k citations indexed

About

Timo D. Müller is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Timo D. Müller has authored 144 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Endocrinology, Diabetes and Metabolism, 64 papers in Physiology and 47 papers in Endocrine and Autonomic Systems. Recurrent topics in Timo D. Müller's work include Diabetes Treatment and Management (51 papers), Regulation of Appetite and Obesity (42 papers) and Adipose Tissue and Metabolism (35 papers). Timo D. Müller is often cited by papers focused on Diabetes Treatment and Management (51 papers), Regulation of Appetite and Obesity (42 papers) and Adipose Tissue and Metabolism (35 papers). Timo D. Müller collaborates with scholars based in Germany, United States and Denmark. Timo D. Müller's co-authors include Matthias H. Tschöp, Richard D. DiMarchi, Christoffer Clemmensen, Brian Finan, Matthias Blüher, Susanna M. Hofmann, M. Tschöp, Diego Pérez–Tilve, Johannes Hebebrand and Stephen C. Woods and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Timo D. Müller

134 papers receiving 6.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-obesity drug discovery: advances and challenges

2021 657 citations Timo D. Müller, Matthias Blüher et al. Nature Reviews Drug Discovery profile →
Animal models of obesity and diabetes mellitus

2018 618 citations Maximilian Kleinert, Susanna M. Hofmann et al. Nature Reviews Endocrinology profile →
The New Biology and Pharmacology of Glucagon

2017 297 citations Timo D. Müller, Brian Finan et al. profile →
Incretin hormones and type 2 diabetes

2023 86 citations Timo D. Müller et al. profile →
Transforming obesity: The advancement of multi-receptor drugs

2024 54 citations Christine M. Kusminski, Diego Pérez–Tilve et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timo D. Müller Germany	44	2.4k	2.3k	2.2k	1.4k	1.4k	144	6.8k
Alessandro Pocai United States	33	1.5k 0.6×	2.2k 1.0×	2.1k 0.9×	2.0k 1.4×	1.6k 1.1×	55	5.9k
Wilhelm Krone Germany	41	1.8k 0.7×	2.6k 1.1×	2.7k 1.3×	1.3k 0.9×	1.6k 1.2×	182	7.8k
Christoffer Clemmensen Denmark	32	1.5k 0.6×	1.9k 0.8×	1.6k 0.8×	798 0.6×	1.2k 0.9×	88	5.2k
Olga D. Carlson United States	37	1.6k 0.7×	2.5k 1.1×	1.3k 0.6×	1.3k 0.9×	1.1k 0.8×	64	5.9k
Nicholas M. Morton United Kingdom	35	3.0k 1.2×	2.1k 0.9×	1.1k 0.5×	1.1k 0.7×	889 0.7×	87	6.1k
David G. Parkes Australia	43	2.7k 1.1×	1.3k 0.6×	1.7k 0.8×	1.5k 1.1×	1.6k 1.2×	112	6.0k
Robin L. Davisson United States	52	1.3k 0.5×	1.9k 0.8×	2.6k 1.2×	923 0.6×	779 0.6×	117	8.1k
Tony K.T. Lam Canada	45	1.5k 0.6×	3.4k 1.5×	2.3k 1.1×	2.5k 1.8×	2.1k 1.5×	105	7.2k
Akira Hirasawa Japan	42	1.8k 0.7×	1.8k 0.8×	4.2k 1.9×	918 0.6×	1.9k 1.4×	148	7.9k
Tatsuya Hayashi Japan	41	1.1k 0.4×	3.4k 1.5×	3.9k 1.8×	1.5k 1.0×	1.7k 1.3×	191	8.2k

Countries citing papers authored by Timo D. Müller

Since Specialization

Citations

This map shows the geographic impact of Timo D. Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo D. Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo D. Müller more than expected).

Fields of papers citing papers by Timo D. Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo D. Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo D. Müller. The network helps show where Timo D. Müller may publish in the future.

Co-authorship network of co-authors of Timo D. Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Timo D. Müller. A scholar is included among the top collaborators of Timo D. Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo D. Müller. Timo D. Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Douros, Jonathan D., Ronald Goldwater, Ann Maria Kruse Hansen, et al.. (2025). A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans. Molecular Metabolism. 96. 102129–102129. 6 indexed citations

Sun, Na, Ahmed Khalil, Arkadiusz Liśkiewicz, et al.. (2025). Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism. Molecular Metabolism. 96. 102136–102136. 1 indexed citations

Müller, Timo D.. (2025). Advances in incretin-based drug discovery in 2025. Nature Reviews Endocrinology. 22(2). 68–69.

Lima, Natália da Silva, Eva Nóvoa, Cristina Riobello, et al.. (2024). GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells. Cellular and Molecular Life Sciences. 81(1). 468–468. 9 indexed citations

Kusminski, Christine M., Diego Pérez–Tilve, Timo D. Müller, et al.. (2024). Transforming obesity: The advancement of multi-receptor drugs. Cell. 187(15). 3829–3853. 54 indexed citations breakdown →

Müller, Günter & Timo D. Müller. (2024). A “poly-matter network” conception of biological inheritance. Genetica. 152(4-6). 211–230. 2 indexed citations

Grandl, Gerald, Aaron Novikoff, Xue Liu, & Timo D. Müller. (2024). Recent achievements and future directions of anti-obesity medications. The Lancet Regional Health - Europe. 47. 101100–101100. 5 indexed citations

Frendo‐Cumbo, Scott, Muhmmad Omar‐Hmeadi, Lucas Massier, et al.. (2024). A spatiotemporal proteomic map of human adipogenesis. Nature Metabolism. 6(5). 861–879. 13 indexed citations

Wunderlich, M, Ronan Le Gleut, Patrick J. Knerr, et al.. (2024). Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice. Molecular Metabolism. 87. 101992–101992.

10.

Novikoff, Aaron & Timo D. Müller. (2023). The molecular pharmacology of glucagon agonists in diabetes and obesity. Peptides. 165. 171003–171003. 34 indexed citations

11.

El, Kimberley, Jonathan D. Douros, Francis S. Willard, et al.. (2023). The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets. Nature Metabolism. 5(6). 945–954. 74 indexed citations

12.

Müller, Günter & Timo D. Müller. (2023). (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins II: Intercellular Transfer of Matter (Inheritance?) That Matters. Biomolecules. 13(6). 994–994. 9 indexed citations

13.

Sundaram, Sivaraj Mohana, Helge Müller‐Fielitz, Meri De Angelis, et al.. (2022). Gene therapy targeting the blood–brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency. Brain. 145(12). 4264–4274. 20 indexed citations

14.

Khajavi, Noushafarin, Andreas Beck, Anouar Belkacemi, et al.. (2022). TRPM7 kinase is required for insulin production and compensatory islet responses during obesity. JCI Insight. 8(3). 11 indexed citations

15.

Schriever, Sonja C., José Manuel Monroy Kuhn, Andreas Peter, et al.. (2021). Correlation guided Network Integration (CoNI) reveals novel genes affecting hepatic metabolism. Molecular Metabolism. 53. 101295–101295. 3 indexed citations

16.

Müller, Timo D., Martin Klingenspor, & Matthias H. Tschöp. (2021). Revisiting energy expenditure: how to correct mouse metabolic rate for body mass. Nature Metabolism. 3(9). 1134–1136. 67 indexed citations

17.

Novikoff, Aaron, Shannon O’Brien, Gerald Grandl, et al.. (2021). Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists. Molecular Metabolism. 49. 101181–101181. 60 indexed citations

18.

Müller, Timo D., Matthias Blüher, Matthias H. Tschöp, & Richard D. DiMarchi. (2021). Anti-obesity drug discovery: advances and challenges. Nature Reviews Drug Discovery. 21(3). 201–223. 657 indexed citations breakdown →

19.

Sachs, Stephan, Lili Niu, Philipp E. Geyer, et al.. (2020). Plasma proteome profiles treatment efficacy of incretin dual agonism in diet‐induced obese female and male mice. Diabetes Obesity and Metabolism. 23(1). 195–207. 16 indexed citations

20.

Habegger, Kirk M., Omar Al–Massadi, Kristy M. Heppner, et al.. (2013). Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut. 63(8). 1238–1246. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact